Ensuring Provider Education And Readiness For Using A Novel CAR T
Source: Precision ADVANCE
- Client was launching a novel CAR T-cell therapy in rare hematologic malignancy and company was new to this space
- Client engaged Precision’s support to mount an effective launch by mapping the patient journey in this complex CAR T-cell therapy process, identifying the pain points for access to therapy and addressing the educational needs across stakeholders
Precision partnered with our client to design and implement comprehensive site training and resources to ensure safe use and patient access at launch.
VIEW THE CASE STUDY! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene X
Subscribe to Cell & Gene